Skip to main content
. 2023 Dec 11;23:e78.

Table 3.

Characteristics of Patients Who Developed Hematoma and Those Who Did Not

Variable V hematoma (N = 12&4) Hematoma (N = *) P value
Age 41.59 ± 23.86 55.88 ± 13.16 .091
Female 957 (99%) 6 (1%) .9627
Male 307 (99%) 2 (1%)
BMI (n = 1163) 23.77 ± 5.31 (n = 7) 23.63 ± 3.71 .9429
ASA I - healthy 224 (100%) 0 (0%) .4691
ASA II - mild systemic Disease 462 (100%) 2 (0%)
ASA Ell - severe systemic Disease 76 (99%) 1 (1%)
ASA IV - incapacitating disease 2 (100%) 0 (0%)
Low VTE 33 (100%) 0 (0%) .3206
Moderate VTE 233 (100%) 0 (0%)
High VTE 524 (99%) 6 (1%)
Highest VTE 125 (98%) 2 (2%)
Time in operating room (Hours) 1.59 ± 1.32 2.11 ± 1.98 .2708
DVT not noted 1263 (99%٥) 8(1%) .9366
DVT present 1 (100%) 0 (0%)
Original Length of stay 0.57 ± 2.75 0.79 ± 0.66 .3831
Never smoker 590 (99%) 4(1%) .8243
Smoker 46 (100%) 0 (0%)
Quit smoking 242 (99%) 2(1%)

There was no statistical significance. ASA, American Society of Anesthesiologist physical status classification system; VTE, venous thromboembolism; DVT, deep venous thrombosis.